Nicole Segalowitz

Nicole Segalowitz, MBA, currently serves as a Clinical Account Executive in Rare Disease at ANI Pharmaceuticals, Inc. since April 2023. Previously, Nicole worked as a Territory Business Manager at Xeris Pharmaceuticals, Inc. from June 2021 to March 2023, and held the role of Regional Account Manager during the transition of Supernus Pharmaceuticals, Inc. acquiring US WorldMeds from June 2020 to June 2021, promoting neurology products focused on Parkinson’s Disease and related conditions. Earlier experience includes Regional Account Manager at US WorldMeds, Senior Respiratory Sales Representative at AstraZeneca, and various roles at Takeda, emphasizing hospital and specialty sales. Academic qualifications include a Master's Degree in Business Administration from the University of Phoenix and a Bachelor's of Science in Public Administration from the University of Central Florida.